FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Sun Pharmaceutical Industries Metformin HCl Extended-Release Tablets Recall

Metformin HCl Extended-Release Tablets, USP, 500 mg, Rx Only, 500-count bottle, Rx only…

SUN PHARMACEUTICAL INDUSTRIES INC · Princeton, NJ

Risk level
Class III
Reported by FDA
Apr 14, 2021
Recall ID
D-0325-2021
Check your lot numberHow we source this data

Summary

Sun Pharmaceutical Industries recalled Metformin HCl Extended-Release Tablets starting Mar 25, 2021. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0325-2021 on Apr 14, 2021. Reason: Failed Moisture Limits: Out of specification for water content. Status: Terminated.

Why it was recalled

Failed Moisture Limits: Out of specification for water content

Product description

Metformin HCl Extended-Release Tablets, USP, 500 mg, Rx Only, 500-count bottle, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512; Manufactured by: Sun Pharmaceutical Industries Ltd., Halol-Baroda HIghway, Halol-389 350 Gujarat, India, NDC 62756-142-02.

Lot numbers, UPCs & expiration codes

Lot #JKU4639A, Exp 10/2022

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0325-2021
Classification
Class III
Status
Terminated
Recall initiated
Mar 25, 2021
FDA report date
Apr 14, 2021
Quantity
2520 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
SUN PHARMACEUTICAL INDUSTRIES INC

Original FDA data

Every field from FDA enforcement report D-0325-2021, exactly as published.

Show all FDA fields
City
Princeton
State
NJ
Status
Terminated
Country
United States
Event ID
87617
Address
2 Independence Way
Code information
Lot #JKU4639A, Exp 10/2022
Postal code
08540-6620
Report date
Apr 14, 2021
Product type
Drugs
Recall number
D-0325-2021
Classification
Class III
Recalling firm
SUN PHARMACEUTICAL INDUSTRIES INC
Product quantity
2520 bottles
Termination date
Apr 14, 2022
Reason for recall
Failed Moisture Limits: Out of specification for water content
Voluntary / mandated
Voluntary: Firm initiated
Product description
Metformin HCl Extended-Release Tablets, USP, 500 mg, Rx Only, 500-count bottle, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512; Manufactured by: Sun Pharmaceutical Industries Ltd., Halol-Baroda HIghway, Halol-389 350 Gujarat, India, NDC 62756-142-02.
Distribution pattern
Nationwide in the USA
Recall initiation date
Mar 25, 2021
Initial firm notification
Letter
Center classification date
Apr 7, 2021

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0325-2021, published Apr 14, 2021. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls